Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Keystone Symposia Global Health Series: Pathogenesis and Control of Emerging Infections and Drug Resistant Organisms

Go back to Resources

Keystone Symposia Global Health Series: Pathogenesis and Control of Emerging Infections and Drug Resistant Organisms

Authors:

Location:

Abstract:

Go back to Resources

Intravitreal Ranibizumab Therapy for Retinal Capillary Hemangioblastoma Related to von Hippel-Lindau Disease

Go back to Resources

Intravitreal Ranibizumab Therapy for Retinal Capillary Hemangioblastoma Related to von Hippel-Lindau Disease

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Intravitreal Ranibizumab for Treatment of Retinal Capillary Hemangioblastoma (RCH) Related to von-Hippel Lindau (VHL) Disease

Go back to Resources

Intravitreal Ranibizumab for Treatment of Retinal Capillary Hemangioblastoma (RCH) Related to von-Hippel Lindau (VHL) Disease

Authors:

Secondary:

Location:

Go back to Resources

Infliximab for the Treatment of Scleritis and Recalcitrant Uveitis

Go back to Resources

Infliximab for the Treatment of Scleritis and Recalcitrant Uveitis

Authors:

Location:

Go back to Resources

Electronic Data Acquisition

Go back to Resources

Electronic Data Acquisition

Authors:

Secondary:

Location:

Go back to Resources

Effects of Breastfeeding in Women Taking Antiepileptic Drugs on Their Children’s Cognitive Outcomes

Go back to Resources

Effects of Breastfeeding in Women Taking Antiepileptic Drugs on Their Children’s Cognitive Outcomes

Authors:

Secondary:

Location:

Go back to Resources

Docosahexaenoic Acid Does Not Improve Visual Function in Patients with Autosomal Recessive Stargardt Disease

Go back to Resources

Docosahexaenoic Acid Does Not Improve Visual Function in Patients with Autosomal Recessive Stargardt Disease

Authors:

Secondary:

Location:

Go back to Resources

Score Study Report 1: Baseline Associations Between Central Retinal Thickness and Visual Acuity in Patients with Retinal Vein Occlusion

Go back to Resources

Score Study Report 1: Baseline Associations Between Central Retinal Thickness and Visual Acuity in Patients with Retinal Vein Occlusion

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Safety and Immunogenicity of a Subvirion Inactivated Influenza a/H5N1 Vaccine With or Without Aluminum Hydroxide Among Healthy Elderly Adults

Go back to Resources

Safety and Immunogenicity of a Subvirion Inactivated Influenza a/H5N1 Vaccine With or Without Aluminum Hydroxide Among Healthy Elderly Adults

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Risk of Advanced Age-Related Macular Degeneration after Cataract Surgery in the Age-Related Eye Disease Study: AREDS Report No. 25

Go back to Resources

Risk of Advanced Age-Related Macular Degeneration after Cataract Surgery in the Age-Related Eye Disease Study: AREDS Report No. 25

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 171
  • Page 172
  • Page 173
  • Page 174
  • Current page 175
  • Page 176
  • Page 177
  • Page 178
  • Page 179
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions

Cookie Policy

Our site uses cookies for analytics and to improve our site and services. You can manage these cookies via your browser settings at any time. By continuing to use our site, you agree to our use of cookies. For more information, including how to change your settings, see our Cookie Policy.